Document Detail

Thrombophilia and fetal loss: Lessons from gene targeting in mice.
MedLine Citation:
PMID:  19217483     Owner:  NLM     Status:  MEDLINE    
Inherited thrombophilia is recognized as one of the causes of recurrent fetal loss. Yet, the risk of fetal loss in women with thrombophilia is far from absolute. Other risk modifiers are clearly involved, but remain to be identified. The mechanism that translates maternal thrombophilia into pregnancy disorder is also not understood. Genetically engineered mice have led to the development of new insights into the etiology and pathogenesis of thrombophilia-associated fetal loss. These insights are the focus of this review.
Rashmi Sood
Related Documents :
11726323 - Factor v leiden mutation and the risk of venous thromboembolism in pregnant women.
17150243 - Thrombelastography monitoring of resistance to enoxaparin anticoagulation in thrombophi...
25281523 - Anesthetic exposure in the treatment of symptomatic urinary calculi in pregnant women.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Thrombosis research     Volume:  123 Suppl 2     ISSN:  0049-3848     ISO Abbreviation:  Thromb. Res.     Publication Date:  2009  
Date Detail:
Created Date:  2009-02-16     Completed Date:  2009-05-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0326377     Medline TA:  Thromb Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S79-84     Citation Subset:  IM    
Medical College of Wisconsin, Milwaukee, WI, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Animals, Genetically Modified
Disease Models, Animal
Factor V / genetics
Fetal Death / blood,  etiology*,  genetics
Mice, Knockout
Pregnancy Complications, Hematologic / blood,  genetics*
Thrombophilia / blood,  complications*,  genetics*
Reg. No./Substance:
0/factor V Leiden; 9001-24-5/Factor V

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mechanisms of thrombosis related to hormone therapy.
Next Document:  Angiogenic factors and preeclampsia.